Prednisone plus bisphosphonate May accelerate remission in selected patients with active Charcot neuro-osteoarthropathy
Endocrine · 10.03.2026 · 91 (1)
DOI: 10.1007/s12020-026-04585-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Endocrine, online erschienen am 10.03.2026. Verfasst von Carmine Gazzaruso und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. carmine.gazzaruso@unimi.it. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. carmine.gazzaruso@unimi.it.
- Diabetes and endocrine-metabolic Diseases Unit, Istituto Clinico Beato Matteo, Gruppo Ospedaliero San Donato, Vigevano, Italy. carmine.gazzaruso@unimi.it.
- Diabetes and endocrine-metabolic Diseases Unit, Istituto Clinico Beato Matteo, Gruppo Ospedaliero San Donato, Vigevano, Italy.
Zitieren
APA
Gazzaruso, C., Gallotti, P., & Coppola, A. (2026). Prednisone plus bisphosphonate May accelerate remission in selected patients with active Charcot neuro-osteoarthropathy. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04585-9
Vancouver
Gazzaruso C, Gallotti P, Coppola A. Prednisone plus bisphosphonate May accelerate remission in selected patients with active Charcot neuro-osteoarthropathy. Endocrine. 2026;91(1). doi:10.1007/s12020-026-04585-9
BibTeX
@article{Gazzaruso2026,
author = {Gazzaruso, Carmine and Gallotti, Pietro and Coppola, Adriana},
title = {Prednisone plus bisphosphonate May accelerate remission in selected patients with active Charcot neuro-osteoarthropathy},
journal = {Endocrine},
year = {2026},
volume = {91},
number = {1},
doi = {10.1007/s12020-026-04585-9}
}
EUVIMED